[Adenovirus-delivered BMI-1 shRNA]

Area of Science:

• Molecular Biology
• Gene Therapy
• Virology

Background:

• Plasmid vectors for small hairpin RNA (shRNA) transcription have limitations, including low and variable transfection efficiency.
• Synthesized small interfering RNA (siRNA) offers an alternative but faces delivery challenges.
• There is a need for efficient and reliable siRNA delivery systems for therapeutic applications.

Purpose of the Study:

• To establish an adenoviral siRNA delivery system overcoming the disadvantages of plasmid vectors.
• To develop an adenoviral vector targeting the human polycomb gene BMI-1 for gene silencing.
• To evaluate the efficiency of adenoviral delivery of siRNA in mammalian cells.

Main Methods:

• Construction of the pAd-BMI-1shRNA-CMV-GFP vector by inserting U6-BMI-1 and CMV-GFP cassettes.
• Production of adenovirus from the 293A packaging cell line.
• Infection of K562 cells with the produced adenovirus and detection of BMI-1 expression via real-time PCR and Western blot.

Main Results:

• Successful production of adenovirus carrying BMI-1shRNA.
• Significant down-regulation of BMI-1 mRNA and protein levels in K562 cells after adenoviral transfection.
• Control adenoviruses carrying scrambled shRNA showed no effect on BMI-1 expression.

Conclusions:

• Adenoviruses serve as efficient vectors for delivering siRNA into mammalian cells.
• Adenoviral siRNA delivery systems demonstrate potential for gene therapy applications.
• This system effectively silences target gene expression, offering a promising therapeutic strategy.